Dow Chemical has joined forces with leading pharmaceutical drug-delivery research company, Bend Research Inc., to offer drug-solubility solutions and new polymers. The terms of the deal were not disclosed.
[body]Bend Research specializes in the development and commercialization of pharmaceutical technologies. Its leading drug development and delivery technologies include spray-dried dispersion (SDD), controlled-release, inhalation and biotherapeutics technologies.
Under the collaboration, the companies will develop and market SDD solutions which address technology gap in drug manufacturing and delivery. Moreover, they will deliver new polymers having the ability to tailor materials to meet the performance needs of specific drugs. Dow will offer hypromellose and hypromellose acetate succinate to tailor these materials and next-generation cellulosic and noncellulosic polymers for improved performance.
Read more at Nasdaq
[/body]
No comments:
Post a Comment